1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA: A Cancer Journal for Clinicians. 2020; 70: 7-30. https://doi.org/ 10.3322/caac.21590.
2. Qian ZJ, Jin MC, Meister KD, Megwalu UC. Pediatric Thyroid Cancer Incidence and Mortality Trends in the United States, 1973-2013. JAMA Otolaryngol Head Neck Surg. 2019; 145: 617-623. https://doi.org/ 10.1001/jamaoto.2019.0898.
3. Liu Z, Hu D, Huang Y, et al. Factors associated with distant metastasis in pediatric thyroid cancer: evaluation of the SEER database. Endocr Connect. 2019; 8: 78-85. https://doi.org/ 10.1530/ec-18-0441.
4. Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013. JAMA. 2017; 317: 1338-1348. https://doi.org/ 10.1001/jama.2017.2719.
5. Francis GL, Waguespack SG, Bauer AJ, et al. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015; 25: 716-59. https://doi.org/ 10.1089/thy.2014.0460.
6. Inaugural Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer: Children Are Not Small Adults. Thyroid. 2015; 25: 713-715. https://doi.org/ 10.1089/thy.2015.0275.
7. Hay ID, Johnson TR, Kaggal S, et al. Papillary Thyroid Carcinoma (PTC) in Children and Adults: Comparison of Initial Presentation and Long-Term Postoperative Outcome in 4432 Patients Consecutively Treated at the Mayo Clinic During Eight Decades (1936-2015). World J Surg. 2018; 42: 329-342. https://doi.org/ 10.1007/s00268-017-4279-x.
8. Karapanou O, Tzanela M, Rondogianni P, et al. Long-term outcome of differentiated thyroid cancer in children and young adults: risk stratification by ATA criteria and assessment of pre-ablation stimulated thyroglobulin as predictors of disease persistence. Endocrine. 2020; 70: 566-574. https://doi.org/ 10.1007/s12020-020-02378-2.
9. Alzahrani AS, Alkhafaji D, Tuli M, Al-Hindi H, Sadiq BB. Comparison of differentiated thyroid cancer in children and adolescents (≤20 years) with young adults. Clin Endocrinol (Oxf). 2016; 84: 571-7. https://doi.org/ 10.1111/cen.12845.
10. Zimmerman D, Hay ID, Gough IR, et al. Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery. 1988; 104: 1157-66.
11. O'Gorman CS, Hamilton J, Rachmiel M, Gupta A, Ngan BY, Daneman D. Thyroid cancer in childhood: a retrospective review of childhood course. Thyroid. 2010; 20: 375-80. https://doi.org/ 10.1089/thy.2009.0386.
12. Cordioli MI, Moraes L, Cury AN, Cerutti JM. Are we really at the dawn of understanding sporadic pediatric thyroid carcinoma? Endocr Relat Cancer. 2015; 22: R311-24. https://doi.org/ 10.1530/erc-15-0381.
13. Li C, Wu Q, Sun S. Radioactive Iodine Therapy in Patients With Thyroid Carcinoma With Distant Metastases: A SEER-Based Study. Cancer Control. 2020; 27: 1073274820914661. https://doi.org/ 10.1177/1073274820914661.
14. Cho SW, Choi HS, Yeom GJ, et al. Long-term prognosis of differentiated thyroid cancer with lung metastasis in Korea and its prognostic factors. Thyroid. 2014; 24: 277-86. https://doi.org/ 10.1089/thy.2012.0654.
15. LaFranchi SH. Inaugural Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer: Children Are Not Small Adults. Thyroid. 2015; 25: 713-5. https://doi.org/ 10.1089/thy.2015.0275.
16. Gupta A, Ly S, Castroneves LA, et al. How are childhood thyroid nodules discovered: opportunities for improving early detection. J Pediatr. 2014; 164: 658-60. https://doi.org/ 10.1016/j.jpeds.2013.10.090.
17. Sugino K, Nagahama M, Kitagawa W, et al. Distant metastasis in pediatric and adolescent differentiated thyroid cancer: Clinical outcomes and risk factor analyses. J Clin Endocrinol Metab. 2020. https://doi.org/ 10.1210/clinem/dgaa545.
18. Alzahrani AS, Alswailem M, Moria Y, et al. Lung Metastasis in Pediatric Thyroid Cancer: Radiological Pattern, Molecular Genetics, Response to Therapy, and Outcome. J Clin Endocrinol Metab. 2019; 104: 103-110. https://doi.org/ 10.1210/jc.2018-01690.
19. Pawelczak M, David R, Franklin B, Kessler M, Lam L, Shah B. Outcomes of children and adolescents with well-differentiated thyroid carcinoma and pulmonary metastases following ¹³¹I treatment: a systematic review. Thyroid. 2010; 20: 1095-101. https://doi.org/ 10.1089/thy.2009.0446.
20. Chesover AD, Vali R, Hemmati SH, Wasserman JD. Lung Metastasis in Children with Differentiated Thyroid Cancer: Factors Associated with Diagnosis and Outcomes of Therapy. Thyroid. 2020. https://doi.org/ 10.1089/thy.2020.0002.
21. Reiners C, Biko J, Haenscheid H, et al. Twenty-Five Years After Chernobyl: Outcome of Radioiodine Treatment in Children and Adolescents With Very High-Risk Radiation-Induced Differentiated Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 2013; 98: 3039-3048. https://doi.org/ 10.1210/jc.2013-1059.
22. Lee J, Sogutlu G, Leard L, et al. Lung transplantation for pulmonary metastases and radiation-induced pulmonary fibrosis after radioactive iodine ablation of extensive lung metastases from papillary thyroid carcinoma. Thyroid. 2007; 17: 367-9. https://doi.org/ 10.1089/thy.2006.0234.
23. Liu L, Huang F, Liu B, Huang R. Detection of distant metastasis at the time of ablation in children with differentiated thyroid cancer: the value of pre-ablation stimulated thyroglobulin. J Pediatr Endocrinol Metab. 2018; 31: 751-756. https://doi.org/ 10.1515/jpem-2018-0075.
24. Liu L, Zhang X, Tian T, Huang R, Liu B. Prognostic Value of Pre-Ablation Stimulated Thyroglobulin in Children and Adolescents with Differentiated Thyroid Cancer. Thyroid. 2020. https://doi.org/ 10.1089/thy.2019.0585.
25. Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA: A Cancer Journal for Clinicians. 2017; 67: 93-99. https://doi.org/ 10.3322/caac.21388.
26. Spinelli C, Tognetti F, Strambi S, Morganti R, Massimino M, Collini P. Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors. World J Surg. 2018; 42: 2444-2453. https://doi.org/ 10.1007/s00268-018-4487-z.
27. Li G, Li R, Song L, et al. Implications of Extrathyroidal Extension Invading Only the Strap Muscles in Papillary Thyroid Carcinomas. Thyroid. 2020; 30: 57-64. https://doi.org/ 10.1089/thy.2018.0801.
28. Liu L, Zhang X, Tian T, Huang R, Liu B. Prognostic Value of Pre-Ablation Stimulated Thyroglobulin in Children and Adolescents with Differentiated Thyroid Cancer. Thyroid. 2020; 30: 1017-1024. https://doi.org/ 10.1089/thy.2019.0585.
29. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016; 26: 1-133. https://doi.org/ 10.1089/thy.2015.0020.
30. Gharib H, Papini E, Garber JR, et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES--2016 UPDATE. Endocr Pract. 2016; 22: 622-39. https://doi.org/ 10.4158/ep161208.Gl.
31. Alzahrani AS, Alswailem M, Alswailem AA, et al. Genetic Alterations in Pediatric Thyroid Cancer Using a Comprehensive Childhood Cancer Gene Panel. J Clin Endocrinol Metab. 2020. https://doi.org/ 10.1210/clinem/dgaa389.
32. Rangel-Pozzo A, Sisdelli L, Cordioli MIV, et al. Genetic Landscape of Papillary Thyroid Carcinoma and Nuclear Architecture: An Overview Comparing Pediatric and Adult Populations. Cancers (Basel). 2020; 12. https://doi.org/ 10.3390/cancers12113146.
33. Liu R, Bishop J, Zhu G, Zhang T, Ladenson PW, Xing M. Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer: Genetic Duet of BRAF and TERT Promoter Mutations in Thyroid Cancer Mortality. JAMA Oncol. 2017; 3: 202-208. https://doi.org/ 10.1001/jamaoncol.2016.3288.
34. Pekova B, Sykorova V, Dvorakova S, et al. RET, NTRK, ALK, BRAF, and MET Fusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas. Thyroid. 2020; 30: 1771-1780. https://doi.org/ 10.1089/thy.2019.0802.
35. Sisdelli L, Cordioli M, Vaisman F, et al. AGK-BRAF is associated with distant metastasis and younger age in pediatric papillary thyroid carcinoma. Pediatr Blood Cancer. 2019; 66: e27707. https://doi.org/ 10.1002/pbc.27707.
36. Cordioli MI, Moraes L, Carvalheira G, et al. AGK-BRAF gene fusion is a recurrent event in sporadic pediatric thyroid carcinoma. Cancer Med. 2016; 5: 1535-41. https://doi.org/ 10.1002/cam4.698.
37. Galuppini F, Vianello F, Censi S, et al. Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and Clinical Scenario. Front Endocrinol (Lausanne). 2019; 10: 552. https://doi.org/ 10.3389/fendo.2019.00552.
38. Bastos AU, de Jesus AC, Cerutti JM. ETV6-NTRK3 and STRN-ALK kinase fusions are recurrent events in papillary thyroid cancer of adult population. Eur J Endocrinol. 2018; 178: 83-91. https://doi.org/ 10.1530/eje-17-0499.
39. Nikita ME, Jiang W, Cheng SM, et al. Mutational Analysis in Pediatric Thyroid Cancer and Correlations with Age, Ethnicity, and Clinical Presentation. Thyroid. 2016; 26: 227-34. https://doi.org/ 10.1089/thy.2015.0401.
40. Seidlin SM, Marinelli LD, Oshry E. Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of the thyroid. CA Cancer J Clin. 1990; 40: 299-317. https://doi.org/ 10.3322/canjclin.40.5.299.
41. Mahajan P, Dawrant J, Kheradpour A, et al. Response to Lenvatinib in Children with Papillary Thyroid Carcinoma. Thyroid. 2018; 28: 1450-1454. https://doi.org/ 10.1089/thy.2018.0064.
42. Kraft IL, Akshintala S, Zhu Y, et al. Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib. Clin Cancer Res. 2018; 24: 753-765. https://doi.org/ 10.1158/1078-0432.Ccr-17-2101.